MedTrace Logo

Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis

NCT01938599 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2016-12-01

No results posted yet for this study

Summary

To compare the safety and efficacy profile of AM001 Cream and its vehicle in the treatment of plaque psoriasis.

Conditions

Interventions

DRUG

AM001 Cream, 7.5%

Cream, 2x daily for 12 weeks

DRUG

Placebo of AM001 Cream

Cream, 2x daily for 12 weeks

Sponsors & Collaborators

  • AmDerma

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-05-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938599 on ClinicalTrials.gov